These innovative medications , Tirzepatide , represent a significant advancement in managing obesity and conceivably related ailments . They all are categorized as GLP-1 pathway activators , signifying these substances to emulate the endogenous GLP-1 substance , stimulating metabolic production and reducing appetite . Despite Tirzepatide each one f